The impacts of pretreatment circulating eosinophils and basophils on prognosis of stage Ⅰ–Ⅲ colorectal cancer

ConclusionPretreatment circulating eosinophils < 0.095 × 109/L/0.055 × 109/L and circulating basophils < 0.015 × 109/L have significant impacts on prognosis of stage I–III CRC patients.
Source: Asia-Pacific Journal of Clinical Oncology - Category: Cancer & Oncology Authors: Tags: ORIGINAL ARTICLE Source Type: research